Want to see SE:MNTC full AI Analyst Report?
MNTC Stock Chart & Stats
kr13.40
kr0.70(3.37%)
At close: 4:00 PM EST
kr13.40
kr0.70(3.37%)
Day’s Range― - ―
52-Week Rangekr8.50 - kr18.00
Previous CloseN/A
Volume190.00
Average Volume (3M)19.32K
Market Cap
kr386.73M
Enterprise Valuekr325.16
Total Cash (Recent Filing)kr61.07M
Total Debt (Recent Filing)kr13.56M
Price to Earnings (P/E)―
Beta0.70
Next Earnings
Nov 10, 2026EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding28,125,734
10 Day Avg. Volume26,429
30 Day Avg. Volume19,315
Financial Highlights & Ratios
PEG Ratio-0.19
Price to Book (P/B)2.71
Price to Sales (P/S)1.34
P/FCF Ratio-14.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.16
Revenue Forecast (FY)kr318.25M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthRevenue growth indicates improving demand for Mentice's simulation solutions and broader adoption across hospitals, training centers, and medical device customers. Sustained growth would strengthen operating leverage and support the platform's long-term commercial potential.
Cash Flow RecoveryPositive operating and free cash flow improves the company's ability to fund product development, customer deployments, and support without relying as heavily on external capital. This is an important recovery in financial flexibility, despite remaining variability.
Conservative LeverageLow leverage and a substantial equity base reduce balance-sheet pressure while the company works toward sustainable profitability. This provides greater flexibility to invest in simulation software, training content, and commercial expansion through changing demand conditions.
Bears Say
Continued Net LossesMentice has not yet demonstrated durable bottom-line profitability, limiting confidence in the scalability of its business model. Continued losses can constrain reinvestment capacity and may require further execution improvements before growth translates into shareholder returns.
Volatile Cash GenerationCash-flow volatility makes internal funding less predictable and suggests exposure to uneven customer deployments, working-capital movements, or project timing. Even with a positive TTM result, inconsistent conversion of activity into cash remains an execution risk.
Uncertain Revenue RecurrenceMentice combines system sales with licenses, content, updates, services, and industry programs, but the recurring share is unknown. Limited visibility into revenue quality and customer concentration makes long-term forecasting and assessment of business durability more difficult.
Mentice AB News
MNTC FAQ
What was Mentice AB’s price range in the past 12 months?
Mentice AB lowest stock price was kr8.50 and its highest was kr18.00 in the past 12 months.
What is Mentice AB’s market cap?
Mentice AB’s market cap is kr386.73M.
When is Mentice AB’s upcoming earnings report date?
Mentice AB’s upcoming earnings report date is Nov 10, 2026 which is in 82 days.
How were Mentice AB’s earnings last quarter?
Mentice AB released its earnings results on Jul 23, 2026. The company reported -kr0.016 earnings per share for the quarter, beating the consensus estimate of -kr0.1 by kr0.084.
Is Mentice AB overvalued?
According to Wall Street analysts Mentice AB’s price is currently Overvalued.
Does Mentice AB pay dividends?
Mentice AB does not currently pay dividends.
What is Mentice AB’s EPS estimate?
Mentice AB’s EPS estimate is -0.05.
How many shares outstanding does Mentice AB have?
Mentice AB has 28,125,734 shares outstanding.
What happened to Mentice AB’s price movement after its last earnings report?
Mentice AB reported an EPS of -kr0.016 in its last earnings report, beating expectations of -kr0.1. Following the earnings report the stock price went up 9.259%.
Which hedge fund is a major shareholder of Mentice AB?
Currently, no hedge funds are holding shares in SE:MNTC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mentice AB
Mentice AB (publ), founded in 1998 and headquartered in Gothenburg, Sweden, specializes in delivering advanced endovascular simulation solutions. These are utilized by educational institutions, healthcare systems, and medical device manufacturers globally, with the company's operations spanning across Europe, the Middle East, Africa, the Asia Pacific region, and the Americas. Its business is structured across distinct segments focusing on the Medical Device Industry, Healthcare Systems, and Strategic Alliances. The company offers a comprehensive suite of software modules designed for training in a wide array of interventional procedures. These include acute ischemic stroke, atrial septal defect/patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee, carotid, and renal interventions, along with patient-specific simulations. The portfolio further encompasses advanced and essential coronary procedures, intermediate coronary, left atrial appendage occlusion, neurovascular coiling and thrombectomy, peripheral angiography, prostatic and uterine artery embolization, radiation safety, transarterial chemoembolization, transseptal puncture, vascular trauma, and cardiac rhythm management. Additionally, Mentice provides crucial support for interventionalists transitioning from transfemoral to transradial access techniques. Beyond software, Mentice's product line features sophisticated medical simulators for endovascular therapies, accompanied by compatible accessories and extensions. They also supply specialized silicone vasculature, as well as cardiac, vascular, and neurovascular flow systems. Innovative digital offerings include the Mentice Right Heart Cath App, a mobile tool for interactive exploration of right heart catheterization procedures, and the Mentice Live Learning Center, which facilitates remote learning through its VIST G endovascular simulation platform. All these comprehensive solutions are engineered to educate, train, and significantly enhance the skills of medical professionals.
Technical Analysis
Getinge
―
Xvivo Perfusion AB
―
Bactiguard Holding AB
―
Sectra AB Class B
―
Scandinavian Real Heart AB
―